Bile acid diarrhoea
Also known as: Bile acid diarrhea, Bile salt diarrhoea, Bile acid malabsorption, Bile salt malabsorption
Bile acid diarrhoea (BAD) results from an excessive concentration of bile acids entering the colon, precipitating watery stools, faecal urgency, and potential faecal incontinence. Pathogenesis often follows ileal resection, ileal pathology, cholecystectomy, or idiopathic dysregulation of bile acid synthesis. Precise medical diagnosis is required to differentiate BAD from irritable bowel syndrome with diarrhoea (IBS-D); primary management involves bile acid sequestrants and clinical nutritional intervention. TCM serves exclusively as adjunctive symptomatic support. Current citations refer to IBS, a herbal trial for IBS-D, and animal-model research regarding antibiotic-associated diarrhoea; they do not constitute established evidence for BAD. There is no specific acupuncture evidence for this condition, and the cited research does not validate the listed formulas. Mechanistic findings are not a substitute for clinical evidence of patient benefit.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Maintain a clinical diary recording stool frequency, Bristol Stool Scale morphology, urgency, faecal incontinence episodes, and the timing of meals and medication.
- •Consult a dietitian regarding individual fat tolerance; avoid extreme lipid restriction or broad elimination diets without professional nutritional supervision.
- •Maintain adequate hydration and seek clinical advice regarding oral rehydration solutions during exacerbations, particularly in patients with co-morbid renal or cardiac disease.
- •Ensure reliable access to facilities, employ gentle perianal skin care, and maintain regular meal timing to minimise symptomatic disruption.
Cautions & Contraindications
- •Do not replace diagnostic assessment or prescribed bile acid sequestrants with acupuncture or herbs. The IBS reviews and IBS-D trial do not establish efficacy for confirmed bile acid diarrhoea or for the listed formulas.[,,]
- •Defer elective needling and herbal initiation during significant dehydration, suspected infection, bleeding or acute severe pain pending medical assessment. This is precautionary clinical guidance, not a contraindication tested in the supplied studies.[,,]
- •Pregnancy, breastfeeding, anticoagulation, immunosuppression and significant liver or kidney disease require individual risk assessment before herbs or acupuncture. The supplied abstracts do not establish safety in these populations.[,,]
- •Arrange pharmacist review of all oral products: bile acid sequestrants can interfere with absorption, and herbal mixtures may add interaction risks. Product-specific timing and interaction advice cannot be inferred from the supplied IBS-D trial.[]
When to reassess or seek care again
Record a seven-day baseline, then review after 2–4 weeks of any adjunctive care: daily stool frequency, Bristol form, urgency episodes, accidents, nocturnal symptoms, weight and interference with activities. Document medicine changes separately. Stop or revise adjunctive treatment if there is no meaningful improvement; refer earlier for deterioration, adverse effects or diagnostic uncertainty, and escalate immediately for red flags.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Frontiers in medicine · 2026
- International journal of general medicine · 2025
- Journal of traditional and complementary medicine · 2026
- Pharmaceuticals (Basel, Switzerland) · 2025
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
